Physician profile
Timothy Bailey
NPI 1225331945
$338.98
in general payments reported to CMS, 2019-2025
10 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.97 · 2021: $30.20 · 2023: $73.53 · 2024: $26.10 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $93.62 | 2025 | Natroba, Spinosad |
| Novo Nordisk INC | $82.93 | 2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $49.04 | 2023 | |
| Boston Scientific Corporation | $26.10 | 2024 | |
| Abbott Laboratories | $24.49 | 2023 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $18.63 | 2025 | Austedo Xr |
| Horizon Therapeutics Plc | $17.27 | 2021 | |
| Sun Pharmaceutical Industries INC. | $13.97 | 2020 | |
| Avanir Pharmaceuticals, INC. | $12.93 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.